论文部分内容阅读
一、用于急性胰腺炎的胰酶抑制剂的评价最初的胰酶抑制剂,是从牛肺中提取的抑肽酶。该药于1953年由Freg首先作了临床病例报告。到60年代对抑肽酶的临床应用效果已做了大量的实验研究。抑肽酶的投用方法多数是经静脉给药,只有极少数是通过腹腔动脉给药。抑肽酶能降低死亡率的报告较多,而对胰腺自身病变的改善尚无定论。因抑肽酶能抑制血中的胰酶,故可见有改善全身症状的效果。另一方面,也有极少数通过灌流胰腺的动脉直接注射胰酶抑
First, the evaluation of pancreatic enzyme inhibitors for acute pancreatitis The initial trypsin inhibitor is aprotinin extracted from the bovine lung. The medicine was first reported by Freg in 1953 in clinical cases. To 60 years of aprotinin clinical effect has done a lot of experimental study. Most aprotinin administration methods are administered intravenously, and only a very small number are given through the celiac artery. Aprotinin can reduce the mortality of more reports, and the improvement of the pancreatic disease itself is not conclusive. Because aprotinin can inhibit the pancreatic enzymes in the blood, it can be seen that there is the effect of improving systemic symptoms. On the other hand, a very small number of pancreatic enzymes are injected directly into the pancreas through the pancreas